isocarboxazid has been researched along with Ptosis, Eyelid in 3 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nematollahi, J | 3 |
| Nulu, JR | 2 |
| Guess, W | 1 |
| Autian, J | 1 |
3 other studies available for isocarboxazid and Ptosis, Eyelid
| Article | Year |
|---|---|
Imidazolecarboxyhydrazides. II. Chemistry and biological evaluation.
Topics: Animals; Blepharoptosis; Body Temperature; Depression, Chemical; Dicarboxylic Acids; Drug Synergism; | 1969 |
Imidazolecarbohydrazides. 3. Chemistry and biological evaluation.
Topics: Animals; Blepharoptosis; Body Temperature Regulation; Chemical Phenomena; Chemistry; Hydrazines; Hyp | 1969 |
Imidazolecarboxhydrazides. I. Chemistry and biological evaluation.
Topics: Animals; Blepharoptosis; Blood Pressure; Chemistry, Organic; Drug Synergism; Electrocardiography; El | 1966 |